close
close

Advances in prevention and treatment of diabetic retinopathy

Posted on by Sweet

The global prevalence of diabetes continues to rise and is expected to affect 700 million people by 2045. This increase is accompanied by significant growth in complications associated with diabetes, with diabetic retinopathy (DR) emerging as one of the diseases the most problematic due to its impact on vision and health. quality of life. Currently, DR is the leading cause of preventable blindness among working-age adults worldwide, with approximately 22% of people with diabetes experiencing some level of DR and more than 10% experiencing vision-threatening stages. Major risk factors for the development and progression of DR include prolonged hyperglycemia, hypertension, and duration of diabetes. Advances in early detection, including AI-based screening systems, and therapeutic interventions have offered new hope. However, the persistence of DR as a major cause of blindness highlights the need for continued research into preventive and therapeutic strategies.

This collection aims to answer pressing questions in the prevention and treatment of diabetic retinopathy, with the goal of reducing the incidence of blindness and improving the quality of life of diabetic patients. The goal is to explore innovative approaches that address gaps in early intervention, optimize current treatment options, and investigate emerging therapeutic modalities for DR. By bringing together these studies, this collection aims to consolidate current advances in DR prevention and treatment, providing information to alleviate the burden of DR and improve patient outcomes in DR care. diabetes. To achieve this, this collection aims to attract the following sub-themes:

• Early detection and prevention: Highlight innovative early detection strategies for DR, including AI-based screening tools and lifestyle interventions aimed at delaying the onset of the disease.

• Therapeutic Advances: Evaluate established and emerging treatments, including anti-VEGF, laser therapy, steroids, and surgical interventions, to optimize the management of DR.

• Technological and pharmacological innovations: Examine cutting-edge approaches in AI and personalized medicine to improve treatment precision and patient outcomes.


Keywords: Diabetic, Retinopathy, Treatment, Therapeutic, Prevention, Technology


Important note: All contributions to this research topic must fall within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more appropriate section or journal at any stage of peer review.

The global prevalence of diabetes continues to rise and is expected to affect 700 million people by 2045. This increase is accompanied by significant growth in complications associated with diabetes, with diabetic retinopathy (DR) emerging as one of the diseases the most problematic due to its impact on vision and health. quality of life. Currently, DR is the leading cause of preventable blindness among working-age adults worldwide, with approximately 22% of people with diabetes experiencing some level of DR and more than 10% experiencing vision-threatening stages. Major risk factors for the development and progression of DR include prolonged hyperglycemia, hypertension, and duration of diabetes. Advances in early detection, including AI-based screening systems, and therapeutic interventions have offered new hope. However, the persistence of DR as a major cause of blindness highlights the need for continued research into preventive and therapeutic strategies.

This collection aims to answer pressing questions in the prevention and treatment of diabetic retinopathy, with the goal of reducing the incidence of blindness and improving the quality of life of diabetic patients. The goal is to explore innovative approaches that address gaps in early intervention, optimize current treatment options, and investigate emerging therapeutic modalities for DR. By bringing together these studies, this collection aims to consolidate current advances in DR prevention and treatment, providing information to alleviate the burden of DR and improve patient outcomes in DR care. diabetes. To achieve this, this collection aims to attract the following sub-themes:

• Early detection and prevention: Highlight innovative early detection strategies for DR, including AI-based screening tools and lifestyle interventions aimed at delaying the onset of the disease.

• Therapeutic Advances: Evaluate established and emerging treatments, including anti-VEGF, laser therapy, steroids, and surgical interventions, to optimize the management of DR.

• Technological and pharmacological innovations: Examine cutting-edge approaches in AI and personalized medicine to improve treatment precision and patient outcomes.


Keywords: Diabetic, Retinopathy, Treatment, Therapeutic, Prevention, Technology


Important note: All contributions to this research topic must fall within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more appropriate section or journal at any stage of peer review.